Tegafur

替加氟

Report date: 2023/03/16 20:00:26
NME

Base Information

Drug NameTegafur
Drug Alias NameFtorafur加氟替喃氟啶TegafurumFluorofur +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHead and Neck NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[5] 
Global Approved IndicationsHead and Neck NeoplasmsStomach NeoplasmsColorectal Neoplasms +[4] 
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryEUMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTaiho Pharmaceutical Co LtdJinghua Pharmaceutical Group Co Ltd
Inactive CompaniesFudan University
Active IndicationsHead and Neck NeoplasmsStomach NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeL01BC03
Related LinksWikipediaDrugBankKEGG